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Abstract: To evaluate possible interactions between the renin-angiotensin system (RAS) and the sympathetic nervous
system (SNS) in the systemic circulation upon the intravenous administration of angiotensin II and a set of adrenergic
agonists in normal Sprague-Dawley (SD) rats. Rats were treated with carvedilol, a non-selective β- and selective α1adrenoceptor blocker, in a dose of (5 mg/kg) orally for 7 days, and on day 8, the animals were pentobarbitone-anaesthetized
and prepared for systemic hemodynamic study. Dose-response relationships in terms of elevation in the magnitude
of the mean arterial blood pressure in response to intravenous injection of noradrenaline (NA), phenylephrine (PE),
methoxamine (ME), and angiotensin II (Ang II) were determined. Data, mean ± S.E.M., were subjected to ANOVA with
significance at P < 0.05. Carvedilol blunted the peripheral vascular response to NA, PE, ME, and Ang II (all P < 0.05).
It is concluded that peripheral vasoconstriction induced by Ang II is contributed to by adrenergic action. Furthermore,
there is a cross-talk relationship between RAS and SNS in determining the responsiveness of the peripheral vasculature
to adrenergic agonists and angiotensin II in normal rats.
Key words: Carvedilol, methoxamine, angiotensin II, Sprague-Dawley rats

Bilinci açık Sprague-Dawley sıçanlarının sistemik sirkülasyonunda
sempatik sinir sistemi ve renin-anjiyotensin sistemi arasındaki etkileşim
Özet: Deneyler, bir adrenerjik agonist seti ve anjiyotensin II’nin damar içi yönetimi üzerinde sistemik sirkülasyonda
sempatik sinir sistemi ve renin-anjiyotensin sistem arasında olası etkileşimleri değerlendirmek için bilinci açık,
uyutulmamış erkek sıçanlar üzerinde yürütüldü. Vücut ağırlıkları eşleştirilmiş alınan iç peritoneyal kısma bir gün
öncesinden reserpin enjekte edilmiş (5 mg/kg) 16 Sprague-Dawley sıçanı, kan basınçlarında ani bir düşüşe sebep olan
anjioyotensin II, methokzamin, fenillefrin ve noradrenalinin damariçi kapsül dozlarının alınımından önce, kalp atım
hızı ve ortalama arter kan basıncının ana hatlı ölçümlerine maruz bırakıldı. Deneyler boyunca hayvanların özgürce
hareketlerine izin verildi. Doz-reaksiyon çeşitlenmeleri ortalama kan basıncında artışa sebep olan anjiyotensin
II ve adrenerjik agonistler için kuruldu. Sonuçlar, bilinci açık sıçanların sistemik damar düzeninde anjiyotensin II,
methokzamin, fenillefrin ve noradrenaline karşı vasküler tepkinin önemli derecede arttığını gösterdi (P < 0,05).
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Reserpin vazoaktif ajanlara karşı hem vasküler α1-adrenoseptörlerin hemde AT1 reseptorlerinin duyarlılığını artırdı.
Aynı zamanda elde edilen sonuçlar bilinci açık Sprague-Dawley sıçanlarında anjiyotensin II reseptörleri ve adrenerjik
nörotransmisyon arasındaki olası etkileşimlerin var olduğunu ve adrenerjik olaylar ile sistemik damar düzenlemelerinin
sonuçlandığını açıklar.
Anahtar sözcükler: α1-adrenoseptörler, anjiyotensin II, renin-anjiyotensin sistem, Sprague-Dawley sıçanı, reserpin

Introduction
The interactions between renin-angiotensin
system (RAS) and sympathetic nervous system (SNS)
have been established at different levels and have
been shown to bear prominent pathophysiological
implications. Circulating angiotensin II (Ang II)
can interact with the sympathetic nervous system at
various sites and is believed to influence sympathetic
nerve activity. It acts at presynaptic sympathetic nerve
endings to facilitate sympathetic neurotransmission
(1,2) and, hence, facilitates sympathetic influences on
the systemic circulation (3).
A number of experimental and clinical
investigations have shed light on the important role
exerted by the renin-angiotensin and the sympathetic
nervous systems in the homeostatic control of
both blood volume and blood pressure (4,5).
Furthermore, it has been reported that angiotensin
II facilitates the release of noradrenaline from postganglionic noradrenergic nerves via AT1 receptors
(6,7). It is therefore believed that these 2 systems do
not independently operate but mutually interact with
each other in accomplishing their cardiovascular
regulatory functions (3,8).
We have shown previously that the renal
vasoconstriction induced by Ang II is contributed
to by adrenergic action, which is not dependent on
intact renal innervation (8). Furthermore, treatment
with carvedilol (a selective α1- and a non-selective
β-adrenoceptor blocker) using a dose similar to the
one used in this study effectively blunted the renal
vascular response to Ang II without any significant
change in the mean arterial blood pressure in WistarKyoto or spontaneously hypertensive rats (SHR)
(8,9).
With this background, this investigation
attempted to test the hypothesis that there is an
interaction between the RAS and SNS at the vascular
level in the normal state. This interaction is important
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in the control of vascular hemodynamics. Moreover,
these observations will have an important clinical
implication.
Materials and methods
Animals
Sixteen male SD rats weighing 285-307 g were
fed with commercial rat chow (Gold Coin Sdn. Bhd.,
Malaysia) and water ad libitum. They were bred and
maintained in the Animal Care Facility, Universiti
Sains Malaysia, Penang, Malaysia. The animals were
allowed to acclimatize for at least 3 days in the new
environment of controlled temperature and humidity
and with a 12:12-h light-dark cycle. Animal handling
and all procedures on animals were carried out in
accordance with the guidelines of the Animal Ethics
Committee, Universiti Sains Malaysia, Penang,
Malaysia. Animals were randomly divided into 2
groups, namely control and carvedilol treated (n = 8).
Carvedilol pretreatment
The rats were acclimatized for at least 3 days
before they were treated with carvedilol (Dilatrend®,
Roche, Switzerland), a non-selective β- and selective
α1-adrenoceptor blocker in a dose of (5 mg/kg per
day) by oral gavage for 7 consecutive days (8-11).
The animals were then subjected to acute
experiments on day 8 after overnight fasting with free
excess to tap water. The acute experiment was designed
to study the changes in the systemic hemodynamics in
response to exogenously administered noradrenaline
(NA), phenylephrine (PE), methoxamine (ME), and
angiotensin II (Ang II). The baseline values of mean
arterial blood pressure and heart rate were recorded
following completion of surgery and stabilization of
the animal. The rats of the control group were also
subjected to the same experimental protocol except
that they received normal saline (p.o.) instead of
carvedilol.
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Haemodynamic study
Preparation and surgical procedure
The overnight fasted rats were anaesthetized with
sodium pentobarbitone (60 mg/kg i.p.) (Nembutal®,
CEVA, France) and received a maintenance dose
of anaesthetic if needed. The trachea was then
exposed and cannulated to ensure a clear airway,
then the left carotid artery was cannulated to
allow continuous blood pressure and heart rate
measurements via a pressure transducer (P23
ID Gould, Statham Instrument, London, UK)
connected to a computerized data acquisition system
(PowerLab®, ADInstruments, Sydney, Australia).
The left jugular vein was isolated and catheterized
with a PP50 cannula, to which a 50 mL syringe on an
infusion pump (Perfusor secura FT 50 mL, B. Braun)
was attached and normal saline at 3 mL/h infused
intravenously throughout the experiment. Through a
small incision in the abdomen, the urinary bladder
was cannulated to permit free passage of urine while
the animal was anaesthetized.
The rats were then allowed to stabilize for at least
1h before the vasopressure response measurement
experiment started. At the end of the experiment, the
animals were euthanized by an overdose of anesthesia
(Sodium pentobarbitone, Nembutal®, CAVE, France)
and disposed of in accordance with the guidelines
of the Animal Ethics Committee of Universiti Sains
Malaysia, Penang, Malaysia.
Direct systemic vasoconstrictor experiments
Vasoactive agents
Noradrenaline (Sanofi Winthrop, Surrey,
UK), phenylephrine (Knoll, Nottingham, UK),
methoxamine (Wellcome, London, UK), and
angiotensin II (CIBA-GEIGY, Basel, Switzerland)
were used in the hemodynamic study. These agonists
were freshly prepared as stock solutions in normal
saline for each experiment and stored at +4 °C.
Noradrenaline is used as a vasopressor drug; it acts on
both α1- and α2-adrenoceptors, but vasoconstriction
due to its exogenous administration is suggested to
be mediated mainly by α1-adrenoceptors (12,13).
Phenylephrine is a phenylethylamine and a nonselective agonist for α1-adrenoceptors (14,15), while

methoxamine is more selective for α1A-adrenoceptors
(16) as compared to α1D-adrenoceptor subtypes
(17) and its affinity for α1B has not been reported.
Angiotensin II is an oligopeptide and the main
active component of the RAS that has a potent
vasoconstrictor action following activation of AT1
receptors.
Experimental procedure
Vasoactive responses of the peripheral vasculature
involved the administration of vasoactive agents
that led to peripheral vasoconstriction, and hence
elevation of the blood pressure. Bolus doses of each
NA (200, 400, and 800 ng), PE (2, 4, and 8 μg), ME (2,
4, and 8 μg), and Ang II (5, 10, and 20 ng) were given
in ascending and descending manner intravenously
via the left jugular vein so that each dose of each
drug yielded 2 responses. The volume of all agonist
doses injected intravenously in this study was kept at
minimum (50-200 μL). Following the administration
of each agonist, a 10 min time interval was left to
allow washout of the agonist and the return of blood
pressure to the baseline value before administration
of the next agonist. The baseline blood pressure values
were determined from the values at the beginning of
each response.
Data analysis
The vasopressor responses caused by NA, PE, ME,
and Ang II were taken as the average values caused by
each dose of the agonists administered in ascending
and descending orders. The overall mean response
for each dose was taken as the average value of the
pressure responses (change in mean arterial blood
pressure) obtained at each dose of the agonist used.
All data were expressed as mean change ± S.E.M.
of vasopressor responses elicited by all the doses of
agonists and have been compared between the treated
groups and the control. All data were subjected to
two-way ANOVA followed by Bonferroni post hoc
test. Basal values for mean arterial pressure and
heart rate, and body weight of control and carvedilol
treated rats were analyzed using unpaired t-test. The
statistical package Superanova (Abacus In., CA, USA)
was used for the analysis. The differences between the
means were considered significant at the 5% level.
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Results and discussion

NA injection

Baseline values of Mean Arterial Pressure
(MAP) and Heart Rate (HR), and body weight

Response

140
120
100
NA (400 ng)

80

Vasoactive responses
The responses of the systemic vasculature were
solely due to the vasopressor effect of the agonists
administered as shown in Figure 1. NA response is
selected as an example of the time course of acute
vasopressor response of the systemic circulation
following the administration of the agonists. The
intravenous injection of saline in the same volume
with the one used for the agonist dose had no effect
on the systemic blood pressure. The delay of about 9
s at the beginning of the response (Figure 1) is due to
the travel time in the cannula before the agonist can
reach the vasculature and start the effect.
Alpha-adrenergic agonists
Noradrenaline (NA)
It was observed that noradrenaline caused dosedependent increase in MAP in both experimental
groups (Figure 2). The overall mean percentage
values for the responses elicited in the peripheral
vasculature to all doses of NA in the control rats
were significantly blunted after carvedilol treatment
(control; 30 ± 2% vs. carvedilol; 22 ± 2%, P < 0.05)
(Figure 3).
Phenylephrine (PE)
Phenylephrine also caused the same pattern of
result as noradrenaline. It resulted in a dose-related
vasoconstriction in both experimental groups

Washing period

160
Blood pressure (mmHg)

The baseline values of MAP and HR in rats treated
with carvedilol was not significantly different from
the control untreated animals. Furthermore, body
weight values of carvedilol treated rats were similar
to control (Table).

180

Saline injection

60
0

18

36

54

72

90

108 126
Time (s)

144

162

180

198

216

Figure 1. Time course of the vasopressor response to NA in
control SD rats. The change in blood pressure was
measured following administration of a bolus injection
(400 ng) of NA or the same volume of normal saline
(100 μL) intravenously. The delay of about 9 s at the
beginning of the response is due to the travel time in
the cannula before reaching the vasculature. Stippled
lines denote ± S.E.M., n = 5.

(Figure 2). The overall mean values for the changes in
MAP produced by all doses of PE in the control rats
were significantly blunted after carvedilol treatment
(control; 37 ± 3% vs. carvedilol; 24 ± 2, P < 0.05)
(Figure 3).
Methoxamine (ME)
ME was observed to cause peripheral
vasoconstriction in a dose-dependent fashion in both
experimental groups (Figure 2). The overall mean
percentage increase in MAP caused by all doses of
ME in untreated control rats was significantly blunted
following treatment with carvedilol (control; 14 ± 1%
vs. carvedilol; 11 ± 0.8%, P < 0.05) (Figure 3).
Angiotensin II (Ang II)
Ang II also caused the same pattern of results as
in the case of NA, PE, and ME. It resulted in a dose-

Table. Basal values of mean arterial blood pressure and heart rate, and body weight values in comparison between carvedilol treated
and control SD rats. * indicates P < 0.05 between the treated group and the control.

Rats

SD
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Treatment

n

Body weight (g)

Mean Arterial
Pressure (mmHg)

Heart Rate (bpm)

Control

8

289 ± 4

119 ± 3

310 ± 3

Carvedilol

8

296 ± 7

116 ± 5

318 ± 10
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Carvedilol

60

60

50

50

40

*
30
20

% increase in MAP

% increase in MAP

Control

20

0
200

400
800
Noradrenaline (ng)

30

30

25

25

20
15

*

10
5

% increase in MAP

% increase in MAP

30

10

10
0

*

40

2

4
8
Phenylephrine ( μg)

20

*

15
10
5

0

0
2

4
8
Methoxamine ( μg)

5

10
20
Angiotensin II ( ng)

Figure 2. Vasopressor responses to graded doses of NA, PE, ME, and Ang II in control, and
carvedilol treated SD rats. Data presented as mean ± S.E.M. (n = 8). * indicates P
< 0.05 between carvedilol treated group and control.

related vasoconstriction in both experimental groups
(Figure 2). The mean values for the increase in MAP
produced by all doses of Ang II in the control rats
were significantly blunted following treatment with
carvedilol (control; 17 ± 1% vs. carvedilol; 12 ± 0.8%,
P < 0.05) (Figure 3).
A large body of evidence suggests that the reninangiotensin system interacts with the sympathetic
nervous system. It is also known that this kind
of interaction exists in the renal vasculature of
WKY and SHR (8,9). Ang II facilitates the release
of endogenous noradrenaline by activation of
presynaptic AT1-receptors (18). The present study
further investigated a possible interactive role between
AT1-receptors and adrenoceptors in modulating
the peripheral vasoconstriction responses in the

normal state. Moreover, it was shown that Ang IIinduced renal vasoconstriction effect is contributed
to by adrenergic actions (19). It can also influence
the α1-adrenoceptor-mediated neurotransmission
(8). The present findings extend this view to show
that adrenergic blockade blunted the peripheral
vasoconstrictions produced by Ang II along with all
the adrenergic agonists given.
In agreement with previous studies in our
laboratory and others (8-11), the current study
showed that 1 week of oral treatment with carvedilol
did not affect the mean arterial pressure or the
heart rate in normal rats when measured in the
anaesthetized state. Furthermore, we have shown
that carvedilol treatment in the dose used in this
study was effective in producing α1-adrenoceptor
525
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45
Overall % increase in MAP

40
Control

35

Carvedilol

30
25

*

*

20
15

*

*

10
5
0
NA

PE

ME

Ang II

Figure 3. Overall percentage increase in mean arterial pressure
(MAP) due to intravenous bolus doses of NA, PE, ME,
and Ang II in control and carvedilol treated SD rats.
Data presented as mean ± S.E.M. (n = 8). * indicates P
< 0.05 between carvedilol treated rats and control.

blockade as assessed by marked suppression of
vasoconstrictor responses to NA, PE, and ME (8,9).
In addition to that, carvedilol also caused attenuation
of the renal vasoconstrictions to Ang II (9). This
later observation, indeed, indicated an adrenergic
influence in the renal response to Ang II. In this
regard, results of this study are compatible with our
earlier findings (8,9) and with others in anaesthetized
rabbits (19). In line of these observations, we suggest
that there could be an interactive relationship
between postsynaptic α1-adrenoceptors and AT1receptors in the systemic vasculature of SD rat, as
blocking of the former by carvedilol influenced the
sensitivity of the latter to Ang II. Our suggestion

of a possible interactive relationship between RAS
and SNS is further supported by an earlier study in
human that suggested a crosstalk between AT1- and
α1-receptors, and showed that in the presence of
increased sympathetic tone, carvedilol provides AT1
receptor blockade via its α1-adrenoceptor blocking
effects (20). Such crosstalk relationship was proved
to play a pivotal role in the peripheral vasculature
of rats with pressure overload cardiac hypertrophy
(21) and also in the renal vasculature of normal and
hypertensive rats (8,9).
In conclusion, this study showed the impact of
adrenergic blocking by carvedilol on the peripheral
vascular responses to a set of adrenergic agonists and
Ang II. We suggest a cross-talk relationship between
SNS and RAS to exist in the peripheral vasculature of
normal SD rats.
Acknowledgements
It is gratefully acknowledged that Mohammed
H. Abdulla is a recipient of USM Vice Chancellor’s
Award and USM fellowship from the Institute of
Graduate Studies (IPS) of Universiti Sains Malaysia.
Corresponding author:
Mohammed H. ABDULLA
School of Pharmaceutical Sciences,
Universiti Sains Malaysia,
Minden, 11800 Penang - MALAYSIA
E-mail: mdapharm78@yahoo.co.uk.

References
1.

Reid IA. Interactions between ANG II, sympathetic nervous
system, and baroreceptor reflexes in regulation of blood
pressure. Am J Physiol 262: E763-E778, 1992.

2.

3.

526

4.

De Jonge AJ, Thoolen MJMC, Timmermans PBMWM et al.
Interaction of converting enzyme inhibition of converting
enzyme inhibitors with the sympathetic nervous system. Progr
Pharmacol 5: 25-38, 1984.

Sealey JE, Laragh JH. The renin-angiotensin-aldosterone
system for neural regulation of blood pressure and sodium
and potassium homeostasis. In: Laragh JG, Brenner BM. eds..
Hypertension: pathophysiology, diagnosis and management.
Raven Press; 1995: pp. 1763-1795.

5.

Grassi G. Renin-angiotensin-sympathetic crosstalks in
hypertension: reappraising the relevance of peripheral
interactions. J Hypertens 19: 1713-1716, 2001.

Shepherd JT, Mancia G. Reflex control of the human
cardiovascular system. Rev Physiol Biochem Pharmacol 105:
1-99, 1986.

6.

Squire IB, Reid JL. Interactions between the renin-angiotensin
system and autonomic nervous system. In: The reninangiotensin system, Vol. 37. (Eds JIS Robert & MG Nicholis).

M. H. ABDULLA, M. A. SATTAR, N. A. ABDULLAH, K. RL. A. SWARUP, A. H. KHAN, E. J. JOHNS

Gower Medical Publishing; 1993: pp. 1-16.
7.

DiBona GF. Nervous kidney: interaction between renal
sympathetic nerves and renin-angiotensin system in the
control of renal functions. Hypertension 36: 1083-1088, 2000.

8.

Abdulla MH, Sattar MA, Abdul Hye Khan M et al. Influence
of sympathetic and AT(1)-receptor blockade on angiotensin
II and adrenergic agonists-induced renal vasoconstrictions in
spontaneously hypertensive rats. Acta Physiol (Oxf) 195: 397404, 2009.

9.

Abdulla MH, Sattar MA, Abdullah NA et al. Chronic treatment
with losartan and carvedilol differentially modulates renal
vascular responses to sympathomimetics normal Wistar Kyoto
and Spontaneously Hypertensive Rats. Eur J Pharmacol 612:
69-74, 2009.

10.

Rodríguez-Pérez JC, Cabrera JJ, Anabitarte A et al. Effects
of carvedilol in rats with induced chronic kidney failure.
Nefrologia 21: 52-58, 2001.

11.

Rodríguez-Pérez JC, Losada A, Anabitarte A et al. Effects
of the novel multiple-action agent carvedilol on severe
nephrosclerosis in renal ablated rats. J Pharmacol Exp Ther
283: 336-404, 1997.

12.

Jarajapu YPR, Hillier C, MacDonald A. The α1A-adrenoceptor
subtypes mediate contraction in rat femoral resistance arteries.
Eur J Pharmacol 422: 127-135, 2001.

13.

Zacharia J, Hillar C, MacDonald A. α1-adrenoceptor subtypes
involved in vasoconstrictor responses to exogenous and
neurally released in rat femoral resistance arteries. Br J
Pharmacol 141: 915-924, 2004.

14.

Khan MA, Sattar MA, Abdullah NA et al. Alpha1Badrenoceptors
mediate
adrenergically-induced
renal
vasoconstrictions in rats with renal impairment. Acta
Pharmacol Sin 29: 193-203, 2008.

15.

Armenia A, Munavvar AS, Abdullah NA et al. The contribution
of adrenoceptor subtype(s) in the renal vasculature of diabetic
spontaneously hypertensive rats. Br J Pharmacol 142: 719-26,
2004.

16.

Tsujimoto G, Tsujimoto A, Suzuki E et al. Glycogen
phosphorylase activation by two different α1 adrenergic
receptor subtypes: Methoxamine selectively stimulates a
putative α1 adrenergic receptor subtype (α1A) that couples
with Ca++ influx. J Pharmacol Exp Ther 36: 166-176, 1989.

17.

Arévalo-León LE, Gallardo-Ortyz IA, Urquiza-Maryn H et
al. Evidence for the role of α1D and α1A adrenoceptors in
contraction of rat mesenteric artery. Vascul Pharmacol 40: 9196, 2003.

18.

De Jonge A, Knape J, van Meel J et al. Effect of converting
enzyme inhibition and angiotensin receptor blockade
on the vasoconstriction mediated by alpha 1- and alpha
2-adrenoceptor stimulation in pithed normotensive rats.
Naunyn Schmiedebergs Arch Pharmacol 321: 309-313, 1982.

19.

Chen K, Zimmerman G. Angiotensin II-mediated renal
vasoconstriction amenable to α1-adrenoceptor blockade. Eur J
Pharmacol 284: 281-288, 1995.

20.

Batenburg WW, Van Esch JHM, Garrelds IM et al. Carvedilolinduced antagonism of angiotensin II: a matter of [alpha]1adrenoceptor blockade. Hypertension 24: 1355-1363, 2006.

21.

Rathore HA, Munavvar AS, Abdullah NA et al. Interaction
between renin-angiotensin and sympathetic nervous systems
in a rat model of pressure overload cardiac hypertrophy. Auton
Autacoid Pharmacol 29: 171-180, 2009.

527

